BMC Immunology | Home page

BMC Immunology | Home page

BMC Immunology

Featured article: A future treatment for organ rejection?

Pixabay

Exploring the therapeutic potential of the EZH2 inhibitor DZNep  for allograft solid organ rejection, new research finds it can suppress alloreactive T cell ameliorated symptoms in rats suffering early rejection of a kidney transplant.

Read more

Articles

• Recent
• Most accessed

Recent articles RSS

1. RESEARCH ARTICLE

   Immune modulation of CD4+CD25+ regulatory T cells by zoledronic acid

   Hsien Liu, Shih-Han Wang, Shin-Cheh Chen, Ching-Ying Chen, Jo-Lin Lo and Tsun-Mei Lin

   Published on: 25 November 2016
2. METHODOLOGY ARTICLE

   Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells

   Mathieu Surenaud, Céline Manier, Laura Richert, Rodolphe Thiébaut, Yves Levy, Sophie Hue and Christine Lacabaratz

   Published on: 11 November 2016
3. RESEARCH ARTICLE

   The UT family of MHC class I loci unique to non-eutherian mammals has limited polymorphism and tissue specific patterns of expression in the opossum

   Katina V. Krasnec, Anthony T. Papenfuss and Robert D. Miller

   Published on: 8 November 2016
4. RESEARCH ARTICLE

   Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics

   Jeroen van Bergenhenegouwen, Aletta D. Kraneveld, Lieke Rutten, Johan Garssen, Arjan P. Vos and Anita Hartog

   Published on: 28 October 2016
5. RESEARCH ARTICLE

   Inhibition of histone methyltransferase EZH2 ameliorates early acute renal allograft rejection in rats

   Long Li, Yi Zhang, Ming Xu, Ruiming Rong, Jina Wang and Tongyu Zhu

   Published on: 26 October 2016

View all articles